Antihypertensives Market Forecast

Datamonitor
August 17, 2009
SKU: DFMN2421833
License type:
Introduction

Following the patent expiries of angiotensin-II receptor blockers Datamonitor expects antihypertensives sales in the seven major markets to record sales of $29.5 billion in 2018, a drop of over $6 billion compared to 2008.

Reasons to Purchase
  • Quantify the future size of the antihypertensives market and identify opportunities for new products.
  • Learn how recent changes related to product expiries will shape the antihypertensives market.
  • Understand the barriers to uptake for novel antihypertensive agents, and the need for paradigm shift in clinical trial design.
Please Note: this is delivered as a Zip file.